Fulltext

98O_PRTARGETED THERAPY FOR BRAF-MUTANT LUNG CANCER: RESULTS FROM THE EUROPEAN EURAF COHORT STUDY

Gautschi, O. ; Bluthgen, M.V. ; Smit, E.F. ; Wolf, J. ; Früh, M. ; Peters, S. ; Schuler, M. ; Zalcman, G. ; Milia, J. ; Mazieres, J.

In: Annals of Oncology, 2015, vol. 26, p. i61-i61

Aggiungi alla tua lista
    Titre
    • 98O_PRTARGETED THERAPY FOR BRAF-MUTANT LUNG CANCER: RESULTS FROM THE EUROPEAN EURAF COHORT STUDY
    Auteur
    • Gautschi, O.. Medical Oncology, Luzerner Kantonsspital, Lucerne, Switzerland
    • Bluthgen, M.V.. IOT Institut d'Oncologie Thoracique, Gustave Roussy, Paris, France
    • Smit, E.F.. Dept. of Pulmonary Diseases, Vrije University Medical Centre (VUMC), Amsterdam, Netherlands
    • Wolf, J.. CIO Center for Integrated Oncology, University of Cologne, Cologne, Germany
    • Früh, M.. Hematology/Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland
    • Peters, S.. Oncology, Centre Hospitalier Universitaire Vaudois - CHUV, Lausanne, Switzerland
    • Schuler, M.. Innere Klinik (Tumorforschung), Westdeutsches Tumorzentrum Essen, Essen, Germany
    • Zalcman, G.. Service de Pneumologie, CHU de Caen, Caen, France
    • Milia, J.. Thoracic Oncology, CHU Toulouse, Hôpital de Larrey, Toulouse, France
    • Mazieres, J.. Thoracic Oncology, CHU Toulouse, Hôpital de Larrey, Toulouse, France
    Type de document
    • Postprint
    Classification
    • Santé
    Identifiant OAI-PMH
    • oai:doc.rero.ch:299154